Glaucoma implant could replace daily eye drops
NCT ID NCT07641296
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a small ring placed in the eye that slowly releases the drug bimatoprost to lower eye pressure in people with glaucoma or ocular hypertension. The ring is implanted during a quick surgery and may work for up to 3 years. The trial includes 24 adults and compares two different doses of the ring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bimatoprost drug ring system
- What this could lead to
- If it works, this could offer a long-lasting, implant-based way to control eye pressure in glaucoma patients, reducing the need for daily eye drops.
- What could go wrong
- This is a very early phase 1 trial with only 24 people. The implant requires surgery, and it's not yet known if it works better than standard treatments or if there are long-term risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye test match the gold standard for glaucoma?
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Which laser best tames glaucoma pressure?